Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00815594
What this trial is testing

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

Who this might be right for
Bleb VascularityConjunctival Scarring
Capital Medical University 30
Not applicableStudy completedNCT01934465
What this trial is testing

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 300
Testing effectiveness (Phase 2)Ended earlyNCT01668680
What this trial is testing

Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma

Who this might be right for
Colorectal Cancer Metastatic
HaEmek Medical Center, Israel 80
Not applicableUnknownNCT05383066
What this trial is testing

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Peking University First Hospital 490
Not applicableEnded earlyNCT02511756
What this trial is testing

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)

Who this might be right for
Metastatic Colorectal Cancer
Patrick Veit-Haibach 50
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT00055237
What this trial is testing

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Who this might be right for
Kaposi's SarcomaHIV InfectionsHIV Seronegativity
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00165451
What this trial is testing

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Who this might be right for
Neoplasms
Dana-Farber Cancer Institute 20
Early research (Phase 1)UnknownNCT00262327
What this trial is testing

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Not applicableUnknownNCT04952688
What this trial is testing

Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Georges Francois Leclerc 30
Early research (Phase 1)Ended earlyNCT00287495
What this trial is testing

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Who this might be right for
Kaposi's SarcomaHHV-8KSHV
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00387764
What this trial is testing

Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 80
Early research (Phase 1)Ended earlyNCT00630318
What this trial is testing

Testing New Method of Analyzing MR Images

Who this might be right for
Breast Abnormalities
Indiana University 12
Not applicableUnknownNCT04639284
What this trial is testing

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT06255392
What this trial is testing

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Who this might be right for
Fludzoparib" and Anti-angiogenicHRD-positive/HER2-negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Large-scale testing (Phase 3)Study completedNCT00561470
What this trial is testing

Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 1,226
Testing effectiveness (Phase 2)Ended earlyNCT01441414
What this trial is testing

PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 18
Large-scale testing (Phase 3)Study completedNCT01235962
What this trial is testing

Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma (RCC)Cancer
Novartis Pharmaceuticals 1,538
Testing effectiveness (Phase 2)Looking for participantsNCT07359053
What this trial is testing

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

Who this might be right for
Sarcoma
Shanghai 6th People's Hospital 46
Next Page